CClinicalTrials.gg
CompletedNCT02950636Updated Apr 30, 2018

Effect of Yoga on Mood and Quality of Life in Patients With Refractory Epilepsy

An interventional study of Yoga in Depression and Anxiety, sponsored by University of Kansas Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-04-30.

Sponsored by University of Kansas Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to learn if a structured yoga program can reduce anxiety, improve depression, and improve quality of life in patients with medication resistant epilepsy (MRE).

02

Conditions studied

  • Depression
  • Anxiety

Keywords

  • Epilepsy
03

In context

Epilepsy

1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.

This study's enrollment of 3 is below the median of 50 across 1,206 interventional studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

University of Kansas Medical Center is the lead sponsor of 483 studies on the registry; 113 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 24 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of unilateral or bilateral temporal lobe epilepsy
  • Presence 3 or more seizures per month
  • No medical contraindications to yoga
  • Willing and able to perform simple non strenuous yoga exercises
  • Ability to get on the floor and up again without assistance
  • Ambulatory
  • Ability to travel to the yoga class twice a week

Exclusion criteria

Exclusion Criteria:

  • Any yoga in the last 6 months
  • Inability to perform yoga exercises
  • History of epilepsy surgery within the last year
  • Currently pregnant or less than 6 week postpartum
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    Restorative Yoga

    Subjects will participate in a structured restorative yoga program. Subjects will attend a 60 minute restorative yoga class twice a week for 8 weeks in a yoga studio.

    Other: Yoga

Interventions

  • OtherYoga

    Restorative Yoga

06

What researchers measure

Primary outcomes

  1. Change in Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)

    The NDDI-E is a 6 item questionnaire. Scores for each question range from 1 (never) to 4 (all the time). There is a maximum score of 24. The higher the score the more severe the depression.

    Time frame: Change from Week 4 to Week 12

Secondary outcomes

  1. Change in Generalized Anxiety Disorder 7-item (GAD-7) scale

    The GAD-7 is a 7 item questionnaire. Scores for each question range from 0 (not at all) to 3 (nearly every day). There is a maximum score of 21. The higher the score the more severe the anxiety. A score over 15 represents severe anxiety. A score under 10 may indicate GAD and would prompt further examination.

    Time frame: Change from Week 4 to Week 12

  2. Change in Quality of Life in Epilepsy-Patient-Weighted (QOLIE-31-p)

    The QOLIE-31-p is a 38 item questionnaire. Scores range from 0-100. Higher scores relate to higher distress.

    Time frame: Change from Baseline to Week 12

  3. Frequency of seizures

    Count of seizures in study subjects

    Time frame: Week 12

07

Study locations

1 site
  • University of Kansas Medical Center
    Kansas City, Kansas 66160, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02950636
Lead sponsor
University of Kansas Medical Center
Collaborators
National Institutes of Health (NIH)
Responsible party
Sponsor
First posted
Nov 1, 2016
Start date
Dec 2016
Primary completion
Jun 2017
Completion
Oct 4, 2017
Last update
Apr 30, 2018

Study contacts

Nancy Hammond, MD
principal investigator · University of Kansas Medical Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion